Anhui COVID-19 vaccine maker able to produce 300m doses a year
Employees of Anhui Zhifei Longcom Biopharmaceutical Co Ltd work on the trial production of COVID-19 vaccine. [Photo/WeChat account: hefeigaoxinfabu]
Chinese vaccine maker Anhui Zhifei Longcom Biopharmaceutical Co Ltd has announced that it is expected to have an annual production capacity of 200 million to 300 million doses of a COVID-19 vaccine, according to local media.
The company is carrying out phase-3 clinical trials for its COVID-19 vaccines, which will hit the market after completing the trials and receiving approval from China's Food and Drug Administration.
Local media said the company has begun trial production of COVID-19 vaccines.
Located in the Hefei National High-Tech Industry Development Zone, Anhui Zhifei Longcom Biopharmaceutical Co Ltd is the only company developing a COVID-19 vaccine in Anhui province.
- |
Peng began to participate in the research of quantum science and technology in 2003. Since then, he has taken part in...
- |
Cao is not only a successful entrepreneur but also an advocate for the development of the national clean energy indus...
